May 20-21, 2019
Rome, Italy
About Conference
Hosted by Pulsus Conferences, 25th of its series, Global Meet on Cancer Research and Oncology will mark the gathering of World renowned experts involved in Cancer Research at Rome. The noxious nature of Cancer has initiated thousands of research to be undertaken by the labs worldwide. With such a great no of researchers working on Caner, till date, no profound cure for this is recorded. It is a matter of pride that these researchers have helped in evolving the resources available for the Oncology but the lack of communication between the researchers worldwide has resulted in delayed and inefficient research.
We, at CANCER 2019, aim to bring Academicians, major Researchers, Oncologists, Consultants, Scholars, Business Delegates, and Manufacturers under one roof to share their works and help in accelerating the Cancer Research around the globe. We provide a platform to share the knowledge, promote Industrial Collaboration and Honour the future prospects in this research area.
Why attend?
25th Global Meet on Cancer Research and Oncology is a unique event where we promote Academic researchers to share their works and encourage collaboration among Business firms and Researchers. This will benefit the common motto of accelerating the Research process to find a better tomorrow. We also provide chances for the delegates and students to acquire knowledge in these areas so that they can be ready to face the challenges and get to know what the opportunities available in this area are.
Exclusive B2B meetings, Interaction sessions, Panel Discussions, Keynote Speeches, Poster presentations, Oral Presentations etc… are the main highlights of this event.
Target Audience:
Session 1: Cancer Biology
Cancer is the uncontrolled growth of the host cell. This behavior often results in the formation of a lump which is termed as Tumor.
Cancer Biology deals with the total behavior of the cancer cell in the host. This involves finding the cause of the abnormal behavior of cells, how these cancer cells progress and move to other organs, cell growth, metastasis, their effect on usual organ functioning, the role of the host immune system in controlling it etc…
To understand all these aspects one has to study these cells at the molecular level. Signaling between the cells holds the solution for all these. Though the recent research on these has revealed a great amount of knowledge base for many questions related to the cancer progress, diagnosis, cure and Management answers are found only by understanding the basic knowledge obtained after the study Biology of these Cancer Cells.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Cancer Biology Conferences | Tumor Biology Conferences | Malignant Cancer Research | Tumor Research
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 2: Cancer Diagnosis
Cancer is considered to be the main reason for deaths across the globe. The cure for cancer is still a matter of research. However, there are few curing techniques available only if the person is diagnosed at the early growth stages. So cancer diagnosis becomes a very important part of an individual’s survival.
Since the cancer cells exhibit properties of a normal cell till it reaches malignant stages, it becomes difficult to diagnose. However few symptoms can act like the signals for the cancer growth. Once these symptoms are encountered one will have to undergo diagnosis techniques like Biopsy, Radiography etc… Through these methods practitioner will be able to predict the stage of the cancer and survivability of the patients.
Some of the tests conducted to diagnose the Cancer are-
Bone Marrow Aspiration and Biopsy
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography and Computed Tomography (PET-CT) Scans
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Other Cancer Diagnosis Conferences:
Cancer Diagnosis Conferences | Cancer Diagnosis Events | Cancer Diagnosis Meetings | Cancer Diagnosis Meetings
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Cancer Meetings in Canada | Cancer Meetings in Canada | Cancer Events in Canada | Cancer Conferences
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 3: Translational Oncology
Translational Oncology is the field of Cancer Research where a series of research conducted at the labs come out with a novel approach towards cancer therapy. This branch of science involves many interdisciplinary subjects. Researchers here will have to be familiar with all the knowledge.
This is considered to be the next big thing in Cancer Research with great no of employability and Commercial opportunities available. Translational research has advanced from recognizing a solitary change driving genome to the high-throughput cutting edge entire genome sequencing investigations. Late advances in Omics have expanded our insight into the procedures underlying malignancy development.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 4: Organ Specific Cancers
Cancer is one of the main sources of death everywhere throughout the world. Its frequency is demonstrating an expanding pattern in different parts of the earth and has been a noteworthy general medical issue in spite of advances in the comprehension of the atomic and cell occasions that underlie.
Cancers are differentiated by the region of origin in the host body. Till date, 100+ types of cancers have been identified and the research on the same is continuing. There are many categories which are to be unraveled.
Some of the most common cancer types which are seen around the globe are:
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 5: Cancer Immunology
As stated earlier, cancer research is an interdisciplinary subject | Cancer Immunology is a branch of science which deals with the role of host immunity and its behavior to the growth of cancer.
The immune system helps us in fighting against the foreign invaders. However, cancer cells not being foreign cells to the host are very difficult to be identified by the host immunity as a threat. Only when the cancer cells start to release certain molecules which are specific to the cancer cells, host immune cells try to act against the cancer cells.
Cancer immunosurveillance is considered to be the only reliable host mechanism against the Tumor growth in the human body by inhibiting the carcinogenesis and also maintaining a regular cellular homeostasis.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 6: Cancer Nursing
Oncology medical nurses work in a multi-disciplinary group, in an assortment of settings, from the inpatient ward to deep down marrow transplant unit, through to the group. Oncology nurses regularly fill in as your first line of correspondence and help organize the numerous parts of care all through cancer treatment. They may play out various obligations.
An Oncology Nurse gives care to malignancy patients and those in danger of getting the infection. Oncology medical caretakers must oversee both the side effects of a patient's ailment and the reactions of different tumor medications. They screen physical conditions, endorse medicine, and regulate chemotherapy and different medications. Oncology medical attendants witness much enduring | however, this pressure is balanced by the long haul connections they regularly create with patients and their families.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Pharmacology is a branch of Medicine that deals with the use of the drugs their formulations, intake and their mechanism inside the host.
Cancer Pharmacology is a branch of Pharmacology which deals with the drug taken to suppress the growth of cancer. This branch usually deals with the interaction of the drug molecules with the cancer cells, how they behave with the normal host cells and tumor cells, their ability to differentiate both and their mechanism of killing the cancer cells.
Drug Discovery and Development in the field of Oncology is solely depending on Cancer Pharmacology. Here the drug molecules developed will be first tried in the In-silico models later the succeeded ones will be given to the animal models. Approved drugs will be used for the use of humans.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 8: Biomarkers in Cancer Research
Biomarkers are the Biological subjects which are used to detect the presence of tumor in the early stages.
Biomarkers give a capable and dynamic way to deal with understanding the range of tumors with applications in observational and logical the study of disease transmission, randomized clinical trials, screening, analysis, and detection. Characterized as changes in the constituents of tissues or body liquids, these markers offer a method for homogeneous arrangement of a sickness and hazard factor, and they can expand one's fundamental data about the hidden pathogenesis of cancer.
The objectives in tumor explore incorporate discovering biomarkers that can be utilized for the early location of carcinogenesis, outline singular treatments, and to recognize fundamental procedures associated with the malady. Since such a significant number of heap forms are associated with the unhealthy states, the objective is like 'finding a needle in a pile'. In any case, the improvement of many - Omics advancements, for example, genomics and proteomics, has enabled us to screen countless cell pathways at the same time. This has empowered the distinguishing proof of biomarkers and flagging atoms related to cell development, cell passing, and cell digestion. These are additionally encouraging in checking the practical unsettling influence, sub-atomic and cell damage and reaction.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 9: Cancer Genomics and Epigenetics
This is a branch of genomics which deals with the genomic content of the host. How the genomes in the host affect the carcinogenesis and what will happen if simple changes occur in these, what can be done to prevent this from happening or to cure the same.
The entire DNA contained in your cells makes up your genome. In many cells, the genome is bundled into two arrangements of chromosomes: one set each from the parents. These chromosomes are made out of six billion individual DNA letters. In the English letter set, there are 26 letters: A through Z. In the letters in order of our qualities, there are four letters: A, C, G and T. Much the same as the letters in a book make words to recount a story, so do the letters in our genomes. Genomics is the investigation of the grouping of these letters in your DNA and how each series of letters passes data to enable every cell in your body to work legitimately.
In tumor cells, little changes in the hereditary letters can change what a genomic word or sentence implies. A changed letter can make the cell make a protein that doesn't enable the cell to fill in as it should. These proteins can influence cells to develop rapidly and cause damage to the neighboring cells. By concentrating on the cancer genome, researchers can find what letter changes are making a cell turn into a disease. The genome of a tumor cell can likewise be utilized to reveal to one sort of tumor from another. Sometimes, considering the genome in a disease can help distinguish a subtype of growth inside that compose, for example, HER2+ breast tumor. Understanding the malignancy genome may likewise enable a researcher to choose the best treatment for every patient.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 10: Drug Discovery & Development in Cancer Research
Drug discovery is a process where the cure for the disease is found. This is a multistep process which involves a great amount of investment in terms of time and finance.
Cancer is believed not to be cured any drugs. However, there are many instances where people have come out of this disease successfully, thanks to the researchers who have developed some efficient molecules which can suppress and kill the tumor cells.
As a first step, the cause of the disease is identified. Here it might be a molecule or an Organism. Once the cause is identified, a hypothesis for the target molecules are drawn and certain molecule groups are chosen to encounter the target molecule/Organism. In the modern method, these molecules are chosen by algorithms and often selected from the databases based upon their structures and composition. Later these are subjected to the target molecule in silico models. Many of the molecules lose the race here and few make it to the next level of testing where the selected models are subjected to animal models. Once these molecules are proven to be safe and efficient in the animal models, they are approved to test on the human. After rigor testing and monitoring, a suitable molecule with all ideal characteristics is approved by the governing body and released into the market.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 11: Alternative Medicine in Cancer Research
For treating most of the cancer types, drugs from the chemical sources are used. Till date, they are considered to be the reliable sources for the medicines. However, due to the side effects and the cost involved in the development makes it difficult to be available for everyone. This is where alternative medicines come into the light.
Alternative medicines can be of natural sources, therapy etc. They are either provided in supplement with the chemical drugs or prescribed separately. One must take it to the note that alternative medicines may not be very efficient in killing the cancer cells but considering the less no. of effects which it has on the host and affordability, they are being popularized now around the globe.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
The epidemiology of cancer is the investigation of the variables influencing growth, as an approach to construe conceivable patterns and causes. The investigation of growth the study of disease transmission utilizes epidemiological strategies to discover the reason for tumor and to recognize and create enhanced medicines.
This region of study must fight with issues of lead time inclination and length time predisposition. Lead time predisposition is the idea that early analysis may falsely expand the survival measurements of a tumor, without extremely enhancing the regular history of the illness. Length inclination is the idea that slower developing, more sluggish tumor will probably be analyzed by screening tests, however, changes in diagnosing more instances of lethargic malignancy may not convert into better patient results after the execution of screening programs. A related concern is overdiagnosis, the propensity of screening tests to analyze disease that may not really affect the patient's lifespan.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 13: Innovations in Cancer Research and Oncology
Cancer is one of the deadliest diseases in the world may have made it as a priority to find a complete cure for this. The same reason has made much advancement to be evolved in recent years.
Cancer research has brought improvements in Bioinformatics for developing better drug development tools, Radiology to bring better diagnosis tools, Surgery to bring better options to achieve minimal invasive methods.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 14: Medical & Radiation Oncology
Medical Oncology is a type of treatment where Cancer cells are treated with chemotherapy, hormonal therapy, biological therapy, and targeted therapy.
Radiation oncology is a field of cancer treatment where the tumor is treated with the assistance of the radiations.
Radiation treatment utilizes high-energy radiation to contract tumor and murder malignancy cells. X ray-beams, gamma beams, and charged particles are sorts of radiation utilized for cancer treatment.
The radiation might be conveyed by a machine outside the body, or it might originate from radioactive material put in the body close tumor cells. Fundamental radiation treatment utilizes radioactive substances, for example, radioactive iodine, that travel in the blood to murder malignancy cells. About portion of all tumor patients gets some kind of radiation treatment at some point over the span of their treatment.
Radiations subjected to the cancer cells damage the genome of the Cancer cells which ultimately leads to the death of the tumor.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 15: Robotic and Surgical Oncology
Robotic Oncology is the mode of Cancer treatment where cancer is removed with the help of robotic surgery. This mode of treatment is often the least invasive and efficient mode of treatment.
Surgical Oncology is a mode of treatment where the tumor from the body is removed with the help of surgery conducted by the medical surgeons. Though these types of methods are being followed from the log time there are chances of reoccurring of the cancer cells as the cancer cells are only removed but not completely destroyed.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 16: Clinical Trials in Cancer Research
Clinical Trials is the step in drug development where the selected molecules for the disease under study are given to the patients and healthy people and animal models to know its effects.
Once these molecules clear this test without any harmful effects to the subjects under study, they are released into the market by the governing bodies.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 17: Cancer Lifestyle and Nutrition
The World Cancer Research Fund gauges that around 20% of all tumors analyzed in the US are identified with body heftiness, physical latency, overabundance liquor utilization, or potentially poor nourishment, and in this manner could be counteracted.
Bringing changes to one’s lifestyle and diet can reduce their risk of catching cancer. There are many instances where people have survived cancer with strict diet and following a healthy lifestyle which involves daily activities like Yoga, Exercise etc…
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 18: Cancer Medical Case Reports
Medical case reports are the documents where the data obtained from the research and treatment of an individual is obtained. These often help in tracking the recovery of the patient after the treatment.
Here the person under study is strictly monitored and all the data including sickness, drug regime, drug dose and the lifestyle of the patient are noted.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
4th International Conference on Cancer (Cancer 2019). March 20-21, 2019 in Amsterdam, Netherlands | 2nd International Conference on Cancer Therapy (Cancer Therapy Congress). Toronto, Canada on August 26-27, 2019 | 14th World Summit on Oncology and Cancer Science ( Oncology 2019) , July 25-26, 2019 | Philadelphia, USA | 6th Asia Pacific Oncologists Annual Meeting May 13-14, 2019 Singapore (Asia Pacific Oncologists 2019) | 2nd Indo Oncology Summit-19 September 13th - 14th , 2019 | Bhubaneswar, India | 6th International Oncology Conference, October 11-12, 2018, Abu Dhabi, UAE | 8th Interamerican Oncology Conference 17-18 October, 2019 Buenos Aires, Argentina | 2nd International Conference on Cancer Therapy and Oncology(cancer Summit 2019) Rome, Italy May 22-23, 2019.
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 19: Cancer Therapy: Management, Treatment, and Prevention
Decreasing the danger of specific cancer might be conceivable through dietary and another way of life changes. How danger can be decreased relies upon the particular tumor. Tobacco use is straightforwardly connected with 33% of all cancers. Not smoking and maintaining a strategic distance from the introduction to tobacco smoke can significantly decrease the danger of lung, kidney, bladder, and head and neck tumor. Maintaining a strategic distance from the utilization of smokeless tobacco diminishes the danger of malignancy of the mouth and tongue.
Another way of life changes diminish the danger of a few sorts of cancer. Diminishing liquor admission can lessen the risk of liver, and oesophageal cancer. A lessened admission of fat in the eating regimen seems to diminish the danger of breast and colon disease. Evading sun introduction can lessen the danger of skin cancer. Covering uncovered skin and utilizing sunscreen moisturizer with a sun protection factor (SPF) of no less than 15 that secures against both bright An and ultraviolet B light likewise help diminish the danger of skin growth. Utilization of headache medicine and other non-steroidal mitigating drugs (NSAIDs) diminishes the danger of colorectal malignancy.
Relevant Conferences:
Oncology Conferences in Asia | Oncology Conferences in Europe | Oncology Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Session 20: Regenerative Medicine & Stem Cells
Regenerative medication is an interdisciplinary approach that looks to repair or supplant harmed or ailing human cells or tissues to re-establish them into their typical capacity, which holds the guarantee of reforming understanding consideration in the 21st century. It might include the transplantation of undifferentiated organisms, forebear cells or tissue, incitement of the body's own repair forms, or the utilization of cells as conveyance vehicles for restorative agents, for example, genes and cytokines.
This process involves either developing the damaged tissue inside the lab and then transferring it to the host body or inducing the host body to regenerate the cells.
Relevant Conferences:
Cancer Conferences in Asia | Cancer Conferences in Europe | Cancer Conferences in USA
37th World Cancer Conference (World Cancer 2019), October 10-11, 2019 - Dublin, Ireland | 3rd Edition of International Cancer Conference (ICC 2019), London, UK - September 23-25, 2019 | 7th Edition of World Congress on Cancer Research, Survivorship and Management ( Cancer Research 2019) August 22-23, 2019, Tokyo, Japan | 32nd Euro Congress on Cancer Science & Therapy ( Cancer Science 2019), March 07-08, 2019 | Barcelona, Spain | 2nd Global Congress on Cancer Science and Therapy Brussels, Belgium July 22-23, 2019 | NCRI Cancer Conference 3-5 November 2019| Glasgow, UK | ICCR 2019 — International e-Conference on Cancer Research 2019, 09 May 2019 | United Kingdom | Global Conference on Cancer & Therapeutic Approaches (Cancer Congress – 2019). August 19 - 21, 2019; Dubai, UAE
Relevant Associations:
ASCO: American Society of Clinical Oncology | Oncology Professional Organizations | ESMO: European Society for Medical Oncology | Oncology Nursing Society | Society for Neuro-Oncology | Association of Community Cancer Centres: ACCC | ASTRO - American Society for Radiation Oncology | American Psychosocial Oncology Society | EANO - European Association of Neuro-Oncology | Michigan Society of Haematology and Oncology | Singapore Society of Oncology | International Psycho-Oncology Society | Canadian Association of Radiation Oncology | European Society of Surgical Oncology | The American Society of Paediatric Haematology/Oncology | International Society of Oral Oncology (ISOO) | Clinical Oncology Society of Australia | Society of Surgical Oncology.
Market Analysis
Overall Cancer influences in excess of 10 million individuals every year and the frequency of tumor is relied upon to increment by 2.4% every year and estimated to reach14 million every year by 2020. Cancer is the second most normal death in the industrialized world.
Cancer is a sickness portrayed by uncontrolled cell multiplication. Of the in excess of 100 kinds of malignancy, lung, bosom, and colorectal disease represent about a portion of new cases every year in the United States. Lung cancer, which is very connected with cigarette smoking, is in charge of a larger number of deaths than some other type of malignancy. Cigarette smoking and other natural elements are related with the greater part of diseases.
With the developing frequency of malignancy, a developing and maturing total populace and huge medicinal advances, there will keep on being marvelous development in the market for disease finding and treatment items.
Biomarker Market:
The worldwide Cancer biomarker showcase measure was esteemed at USD 10.3 billion in the year 2016 and is evaluated to achieve an estimation of USD 33.7 billion by 2025, developing with CAGR of 14.3 %. Developing predominance of malignancies combined with expanding center around the advancement of focused treatments is a central point avowing positive development of this market.
Cancer is accounted for to be the second driving reason for mortality in the U.S. after cardiovascular issue. The predominance of Breast, prostate, and Lung Cancer has expanded at an exceptionally soak rate with an expected number of more than 1,600 individuals being influenced in the U.S. consistently. In 2017, around 200,000 instances of Breast Cancer have been accounted for in the U.S.
Expanding mindfulness among patients and social insurance experts about the significance of early determination of malignancies and rising interest for the customized drug is foreseen to give this market high development openings in the coming decade. Indicative biomarkers for early determination empower specialists on choosing better treatment choices prompting effective recuperation in lesser time.
Likewise, expanding administrative endorsement of novel medications and diagnostics relating to malignancy biomarkers is assessed to build the selection rate. For example, in 2016, Epigenomics AG, an organization associated with the advancement of novel epigenetic biomarker test reported that its Epi proColon was incorporated by the Chinese government for colorectal tumor (CRC) screening.
Cancer Diagnostics Market:
The worldwide Cancer diagnostics showcase measure was esteemed at USD 124.0 billion of every 2016 and is relied upon to develop at a CAGR of 7.2% over the conjecture time frame. Developing commonness of oncologic cases, consistent innovative headways in diagnostics and expanding interest for powerful screening tests are a portion of the prime variables impelling the interest for screening instruments over the world. What's more, rising mindfulness and strong government activities are some extra factors that are expected to help the development of the division amid the figure time frame.
Cancer is one of the main sources of Deaths over the world, which is ascribed to the heightening predominance of the infection. Hence, medicinal services experts are concentrating on the improvement of viable symptomatic and treatment answers for checking the pervasiveness level. Early location builds the achievement rate of treatment regimens. Therefore, human services organizations and market players through different mindfulness programs are advancing routine check-ups.
Overall Cancer influences in excess of 10 million individuals every year and the frequency of tumor is relied upon to increment by 2.4% every year and estimated to reach14 million every year by 2020. Cancer is the second most normal death in the industrialized world.
Cancer is a sickness portrayed by uncontrolled cell multiplication. Of the in excess of 100 kinds of malignancy, lung, bosom, and colorectal disease represent about portion of new cases every year in the United States. Lung cancer, which is very connected with cigarette smoking, is in charge of a larger number of deaths than some other type of malignancy. Cigarette smoking and other natural elements are related with the greater part of diseases.
With the developing frequency of malignancy, a developing and maturing total populace and huge medicinal advances, there will keep on being marvellous development in the market for disease finding and treatment items.
Biomarker Market:
The worldwide Cancer biomarker showcase measure was esteemed at USD 10.3 billion in the year 2016 and is evaluated to achieve an estimation of USD 33.7 billion by 2025, developing with CAGR of 14.3 %. Developing predominance of malignancies combined with expanding centre around advancement of focused treatments is a central point avowing positive development of this market.
Cancer is accounted for to be second driving reason for mortality in the U.S. after cardiovascular issue. Predominance of Breast, prostate, and lung Cancer has expanded at an exceptionally soak rate with an expected number of more than 1,600 individuals being influenced in the U.S. consistently. In 2017, around 200,000 instances of Breast Cancer have been accounted for in the U.S.
Expanding mindfulness among patients and social insurance experts about the significance of early determination of malignancies and rising interest for customized drug is foreseen to give this market high development openings in the coming decade. Indicative biomarkers for early determination empower specialists on choosing better treatment choices prompting effective recuperation in lesser time.
Likewise, expanding administrative endorsement of novel medications and diagnostics relating to malignancy biomarkers is assessed to build the selection rate. For example, in 2016, Epigenomics AG, an organization associated with the advancement of novel epigenetic biomarker test reported that its Epi proColon was incorporated by the Chinese government for colorectal tumor (CRC) screening.
Cancer Diagnostics Market:
The worldwide Cancer diagnostics showcase measure was esteemed at USD 124.0 billion of every 2016 and is relied upon to develop at a CAGR of 7.2% over the conjecture time frame. Developing commonness of oncologic cases, consistent innovative headways in diagnostics, and expanding interest for powerful screening tests are a portion of the prime variables impelling the interest for screening instruments over the world. What's more, rising mindfulness and strong government activities are some extra factors that are expected to help the development of the division amid the figure time frame.
Cancer is one of the main sources of Deaths over the world, which is ascribed to the heightening predominance of the infection. Hence, medicinal services experts are concentrating on the improvement of viable symptomatic and treatment answers for check the pervasiveness level. Early location builds the achievement rate of treatment regimens. Therefore, human services organizations and market players through different mindfulness programs are advancing routine check-ups .
Cancer Terminologies:
Cancer is an Abnormal/diseased condition where the cells of an individual continue to grow without any control. These cells are referred to as Cancerous cells, proliferate at a higher rate and tend to separate and move out to other Organs. All the cells which emerge from these are carcinogenic in nature and can cause Cancer on other organs.
Metastasis: In general terms, Metastasis is the spread of Pathogenic agent from it’s site of origin to other sites. When a tumor starts to grow, the abnormal proliferation of these cells causes the cancerous cells to disrupt from it’s original site and move onto different Organs in body spreading the cancer. This is often termed as Metastasis.
Other relevant terms: Mitosis | Metaplasia | Dysplasia | Anaplasia | Malignant
Cancer Research Centres
A. K. Khan Healthcare Trust |
Aalborg Hospital - Department of Oncology |
Aarhus University Hospital - Department of Oncology |
Abbotsford Cancer Centre |
Abramson Cancer Center |
Addenbrookes Oncology Centre |
Aichi Cancer Center |
Albert Einstein Cancer Center |
Allan Blair Cancer Centre |
Alvin J. Siteman Cancer Center |
Arizona Cancer Center |
Atlantic Cancer Research Institute |
Azienda Ospedaliera Arcispedale S. Maria Nuova |
Azienda Ospedaliera Universitaria San Martino- IST – Istituto Nazionale per la Ricerca sul Cancro |
B. P. Koirala Memorial Cancer Hospital |
Barbara Ann Karmanos Cancer Institute |
Bay Area Tumor Institute |
Beatson West of Scotland Cancer Centre |
Beaumont Hospital: Cancer Services |
Beijing Cancer Hospital |
Beijing Guang An Men Hospital |
Beijing Ji Shui Tan Hospital - Department of Orthopaedic Oncology Surgery |
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology |
Blokhin Russian Cancer Research Centre |
Brazilian Institute for Cancer Control |
Bristol Haematology and Oncology Centre |
British Columbia Cancer Angency |
Buenos Aires Cancer Center |
Cancer Care Ontario |
Cancer Centre of Southeastern Ontario |
Cancer Hospital and Research institute, Gwalior |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Cancer Institute of New Jersey |
Cancer Therapy & Research Center |
Case Comprehensive Cancer Center |
Catalan Institute of Oncology |
Center for Integrated Oncology (CIO) Cologne Bonn |
Centre Antoine Lacassagne, Nice |
Centre Eugène Marquis, Rennes |
Centre for the North - BC Cancer Agency |
Centre François Baclesse, Caen |
Centre Georges-François Leclerc, Dijon |
Centre Henri Becquerel, Rouen |
Centre Jean Perrin, Clermont-Ferrand |
Centre Léon Bérard, Lyon |
Centre Oscar Lambret, Lille |
Centre Paul Strauss, Strasbourg |
Centro di Riferimento Oncologico - Istituto Nazionale Tumori, Aviano |
Centro di Riferimento Oncologico della Basilicata |
Chao Family Comprehensive Cancer Center |
Charité Comprehensive Cancer Center |
Chiba Cancer Center |
Children's Cancer Institute Australia for Medical Research |
Childrens Hospital Los Angeles: Center for Cancer and Blood Diseases |
Children’s Cancer Hospital Egypt |
Chittaranjan National Cancer Institute |
Christie Hospital NHS Foundation Trust |
Chulabhorn Cancer Center |
City of Hope Comprehensive Cancer Center |
Clatterbridge Cancer Centre |
Cleveland Clinic - Taussig Cancer Institute |
Cliniques Universitaire Saint-Luc Centre du Cancer |
Cold Spring Harbor Laboratory Cancer Center |
Comprehensive Cancer Center - KOC |
Comprehensive Cancer Center Erlangen EMN |
Comprehensive Cancer Center Mainfranken |
Comprehensive Cancer Center of Wake Forest University |
Comprehensive Cancer Center Ulm |
Comprehensive Cancer Center Vienna |
Comprehensive Cancer Centre - Vratsa |
Comprehensive Cancer Centre the Netherlands |
Cork University Hospital: Cancer Centre |
Country Dispensary for Oncological Diseases, Shumen |
Cross Cancer Institute |
Dan L. Duncan Cancer Center |
Dana-Farber/Harvard Cancer Center |
David H. Koch Institute for Integrative Cancer Research at MIT |
Delhi State Cancer Institute |
Department of Pediatric Hematology and Oncology |
Dharmais Hospital - National Cancer Canter |
District Dispensary for Oncological Diseases, Plovdiv |
Dokuz Eylül University, Institute of Oncology |
Duke Cancer Institute |
Dundee Cancer Centre |
Erasmus MC Daniel den Hoed Cancer Center |
European Institute of Oncology |
Fakkous Center for Cancer and Allied Diseases |
Feist-Weiller Cancer Center |
Finsen Centre, Rigshospitalet - Department of Oncology |
FN Brno - Department of Pediatric Oncology |
Fondazione IRCCS Istituto Nazionale dei Tumori |
Fox Chase Cancer Center |
Fraser Valley Cancer Centre |
Fred and Pamela Buffett Cancer Center |
Fred Hutchinson Cancer Research Center |
Fudan University Shanghai Cancer Center |
Fundacion Instituto Valenciano de Oncologia (IVO) |
Galway University Hospital: Cancer Services |
General University Hospital in Prague |
Georgetown Lombardi Comprehensive Cancer Center |
Georgia Regents University - Cancer Centre |
Grand River Regional Cancer Centre |
Gujarat Cancer & Research Institute / Gujarat Cancer Society |
Harold C. Simmons Cancer Center |
Helsinki University Central Hospital |
Henry Moore Institute of Oncology |
Herbert Irving Comprehensive Cancer Center |
Herlev Hospital - Department of Oncology |
Higashi Sapporo Hospital |
Holden Comprehensive Cancer Center |
Hollings Cancer Center |
Hospital Ceske Budejovice - Comprehensive Cancer Centre |
Hospital de Clínicas "Dr. Manuel Quintela" |
Huntsman Cancer Institute |
HUS Department of Oncology |
Hyundai Cancer Institute - Children's Hospital of Orange County |
Hôpital René Huguenin, Saint-Cloud |
IKNL Integraal Kankercentrum Nederland |
Imperial College Healthcare NHS Trust |
Institut Bergonié, Bordeaux |
Institut Claudius Regaud, Toulouse |
Institut Curie, Paris |
Institut de cancérologie de l'Ouest - Paul Papin, Angers |
Institut de cancérologie de l'Ouest - René Gauducheau, Nantes |
Institut de Cancérologie de Lorraine, Nancy |
Institut Gustave Roussy - Child and Adolescent Cancer |
Institut Gustave Roussy, Villejuif |
Institut Jean Godinot, Reims |
Institut Jules Bordet - Oncology Hospital |
Institut Paoli-Calmettes, Marseille |
Institut régional du Cancer Montpellier / Val d’Aurelle |
Institute for Cancer Research - Oslo University Hospital |
Institute for Cancer Research and Treatment |
Institute of Oncology "Prof. Dr. Al Trestioreanu" |
Institute of Oncology Carlos Ardila Lülle |
Institute of Oncology Sremska Kamenica |
Institute of Oncology, Vilnius University |
Instituto Madrileño de Oncología, FondacionGrupo (IMO) |
Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE |
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE |
Instituto Português de Oncologia do Porto Francisco Gentil, EPE |
Istituto di Oncologia Molecolare |
Istituto di Ricerche Farmacologiche Mario Negri |
Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G.Pascale' |
Istituto Oncologico Veneto |
Istituto Regina Elena/Regina Elena Cancer Institute |
Istituto Scientifico Romagnolo per la Cura dei Tumori |
Istituto Superiore di Oncologia |
Istituto Tumori Bari |
Jackson Laboratory Cancer Center |
Jeonbuk Regional Cancer Center |
Jonsson Comprehensive Cancer Center |
Kanagawa Cancer Centre |
Karolinska University Hospital and Institute |
Kimmel Cancer Center |
King Fahad National Centre for Children's Cancer and Research |
King Faisal Specialist Hospital & Research Centre |
King Hussein Cancer Center |
Knight Cancer Institute |
Leiden University Medical Center - Clinical oncology |
Ljubljana Institute of Oncology |
London Regional Cancer Program |
Ludwig Institute for Cancer Research - San Diego Branch |
Maastricht University Medisch Centrum |
Markey Cancer Center |
Marlene and Stewart Greenebaum Cancer Center |
Masonic Cancer Center |
Massey Cancer Center |
Mater Misericordia University Hospital: Oncology |
Mayo Clinic Cancer Center |
MD Anderson Cancer Center |
Melvin and Bren Simon Cancer Center |
Memorial Sloan-Kettering Cancer Center |
Mid-Western Cancer Centre |
Moffitt Cancer Center |
Naef K. Basile Cancer Institute - American University of Beirut Medical Centre |
National Cancer Center, Republic of Korea |
National Cancer Center, Singapore |
National Cancer Institute (Egypt) |
National Cancer Institute of Thailand |
National Center for Tumor Diseases (NCT) Heidelberg |
National Institute of Oncology |
National Oncology Centre, Bulgaria |
National University Cancer Institute, Singapore |
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital |
Newcastle Cancer Centre at the Northern Institute for Cancer Research |
Norris Cotton Cancer Center at Dartmouth |
North Estonia Medical Centre |
NYU Cancer Institute |
Ochsner Cancer Institute |
Odense University Hospital - Department of Oncology |
Ohio State University Comprehensive Cancer Center |
Oncologic Center, UZBrussel |
Oncology Institute "Prof.Dr. Ion Chiricuta" |
Orange County Foundation for Oncology Children and Families |
P.A. Herzen Moscow Cancer Research Institute |
Pakistan Institute of Medical Sciences - Department of Oncology |
Peter MacCallum Cancer Centre |
Purdue University Center for Cancer Research |
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine |
Radium Hospital Foundation |
Regional Cancer Center South |
Regional cancer centre, JIPMER |
Regional Cancer Centre, Thiruvananthapuram |
Rikshospitalet-Radiumhospitalet Medical Center |
Robert H. Lurie Comprehensive Cancer Center |
Roswell Park Cancer Institute |
Royal Marsden |
Sahlgrenska University Hospital - Regional Cancer Center West |
Salk Institute Cancer Center |
San Raffaele Hospital |
Sanford-Burnham Medical Research Institute |
Saskatoon Cancer Centre |
SC RTC Radiology Therapeutic Center |
Sharett Institute of Oncology |
Shaukat Khanum Memorial Cancer Hospital and Research Centre |
Shizuoka Cancer Center |
Sidney Kimmel Comprehensive Cancer Center |
Sindi Ahluwalia Hawkins Centre for the Southern Interior |
Slovak Comprehensive Cancer Centre |
South Australian Comprehensive Cancer Consortium |
South Egypt Cancer Institute |
Southwest German Tumor Center - Comprehensive Cancer Center Tübingen |
Specialist Hospital for treatment of cancer, Dr. Marko Antonov Markov |
St James's Hospital: Medical Oncology |
St Vincent’s University Hospital: Cancer Centre |
St. Jude Children's Research Hospital |
Stanford Cancer Institute |
Starship Children’s Hospital of New Zealand |
Sun Yat-sen University Cancer Center |
Sutter Cancer Center |
Tartu University Hospital |
Tatarstan Cancer Centre |
Tianjin Medical University Cancer Institute and Hospital |
Tochigi Cancer Center |
Tom Baker Cancer Centre |
Tufts Medical Center - Cancer Center |
Tulane Comprehensive Cancer Clinic |
Tumor Center Freiburg |
UAB Comprehensive Cancer Center |
Ubonratchathani Cancer Hospital |
UC Davis Comprehensive Cancer Center |
UC San Diego Moores Cancer Center |
UCSF Helen Diller Family Comprehensive Cancer Center |
Udonthanee Cancer Center |
Uganda Cancer Institute |
UH Seidman Cancer Center |
UNC Lineberger Comprehensive Cancer Center |
University Cancer Center Dresden |
University Cancer Center Hamburg |
University Center for Tumor Diseases Frankfurt (UCT) |
University Hospital Linköping - Regional Cancer Center SouthEast |
University Hospital of Umeå - Regional Cancer Center North |
University Hospital, Varna - Departmemt of Medical Oncology |
University of Chicago Comprehensive Cancer Center |
University of Colorado Cancer Center |
University of Hawaii Cancer Center |
University of Kansas Cancer Center |
University of Michigan Comprehensive Cancer Center |
University of New Mexico Cancer Center |
University of Pittsburgh Cancer Institute |
University of Virginia Cancer Center |
University of Wisconsin Carbone Cancer Center |
Uppsala University Hospital - Regional Cancer Centre Uppsala-Örebro |
USC Norris Comprehensive Cancer Center |
Vancouver Cancer Centre |
Vancouver Island Cancer Centre |
Vanderbilt-Ingram Cancer Center |
Vejle Hospital - Department of Oncology |
Velindre Cancer Centre |
Waterford Regional Hospital: Cancer Centre |
West German Tumor Center, Essen |
Wielkopolskie Cancer Center Poznan |
Windsor Regional Hospital - Cancer Program |
Winship Cancer Institute |
Winthrop P. Rockefeller Cancer Institute |
Wistar Institute Cancer Center |
Yale Cancer Center |
Yonsei Cancer Center |
Masaryk Memorial Cancer Institute |
CA: A Cancer Journal for Clinicians |
Cancer Cell |
Lancet Oncology |
Journal of Clinical Oncology |
Journal of the National Cancer Institute |
Cancer and Metastasis Reviews |
Cancer Research |
Biochimica et Biophysica Acta - Reviews on Cancer |
Clinical Cancer Research |
Stem Cells |
Drug Resistance Updates |
Annals of Oncology |
Breast Cancer Research |
Radiotherapy and Oncology |
Cancer |
Molecular Cancer Therapeutics |
European Journal of Cancer |
Nature Reviews Clinical Oncology |
British Journal of Cancer |
International Journal of Cancer |
Neuro-Oncology |
International Journal of Radiation Oncology Biology Physics |
Cancer Treatment Reviews |
Journal of the National Comprehensive Cancer Network : JNCCN |
Blood Reviews |
Advances in Cancer Research |
Molecular Cancer |
Endocrine-Related Cancer |
Oncotarget |
Breast Cancer Research and Treatment |
Journal of Cancer Survivorship |
Psycho-Oncology |
Cancer Prevention Research |
Seminars in Oncology |
Pigment Cell and Melanoma Research |
Current Opinion in HIV and AIDS |
Annals of Surgical Oncology |
Seminars in Radiation Oncology |
Journal of Thoracic Oncology |
Current Opinion in Oncology |
Cancer Control |
Critical Reviews in Oncology/Hematology |
Cancer Letters |
Cancer Science |
Cancer Causes and Control |
Cancer cytopathology |
Cancer Immunology and Immunotherapy |
BMC Cancer |
Environmental Carcinogenesis and Ecotoxicology Reviews |
Journal of Hematology and Oncology |
Gastric Cancer |
Clinical Genitourinary Cancer |
Targeted Oncology |
Experimental Hematology |
Lung Cancer |
Supportive Care in Cancer |
Cancer Biology and Therapy |
Acta Oncologica |
Translational Oncology |
Future Oncology |
Prostate Cancer and Prostatic Diseases |
Oral Oncology |
European Journal of Surgical Oncology |
Journal of Neuro-Oncology |
Journal of Surgical Oncology |
International Journal of Oncology |
Journal of Cancer Research and Clinical Oncology |
Lymphatic Research and Biology |
Journal of Experimental and Clinical Cancer Research |
Oncology |
Cancer Microenvironment |
Cancer Investigation |
Hematological Oncology |
Hormones and Cancer |
Clinical Oncology |
Recent Patents on Anti-Cancer Drug Discovery |
Cancer Chemotherapy and Pharmacology |
Radiation Oncology |
Therapeutic Advances in Medical Oncology |
Cancer Nursing |
Current Treatment Options in Oncology |
Head and Neck Oncology |
European Journal of Oncology Nursing |
Japanese Journal of Clinical Oncology |
Anti-Cancer Drugs |
Clinical Radiology |
Cancer Cell International |
Oncology Reports |
International Journal of Gynecological Cancer |
American Journal of Clinical Oncology |
Journal of Oncology Practice |
Journal of Ovarian Research |
Journal of Supportive Oncology |
Leukemia Research |
Clinical Colorectal Cancer |
Infectious Agents and Cancer |
Urologic Oncology |
Surgical Oncology |
Sarcoma |
Current Opinion in Supportive and Palliative Care |
European Journal of Cancer Prevention |
OncoTargets and Therapy |
Journal of Gynecologic Oncology |
Anticancer Research |
Breast Cancer: Basic and Clinical Research |
Cancer Management and Research |
Current Hematologic Malignancy Reports |
Immunotherapy |
Cancer Biotherapy and Radiopharmaceuticals |
Pathology Oncology Research |
Breast Journal |
Current Oncology |
Hereditary Cancer in Clinical Practice |
International Journal of Biological Markers |
Cancer Research and Treatment |
International Journal of Clinical Oncology |
Medical Oncology |
Oncology Research |
European Journal of Cancer Care |
Journal of Oncology |
Cellular oncology (Dordrecht) |
Journal of Psychosocial Oncology |
Seminars in Oncology Nursing |
Brachytherapy |
Journal of Cancer Epidemiology |
Cancer Informatics |
Medical Dosimetry |
Head and Neck Pathology |
Practical Radiation Oncology |
CytoJournal |
Journal of Pediatric Oncology Nursing |
World Journal of Surgical Oncology |
Surgical Oncology Clinics of North America |
Clinical and Translational Oncology |
Clinical Medicine Insights: Oncology |
Cancer biomarkers : section A of Disease markers |
Breast Cancer: Targets and Therapy |
Oncology |
Onkologie |
Journal of Medical Imaging and Radiation Oncology |
Journal of the Canadian Urological Association |
Journal of Cancer Education |
Journal of Gastrointestinal Cancer |
Journal of Geriatric Oncology |
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique |
Pediatric Hematology and Oncology |
Frontiers of Radiation Therapy and Oncology |
Indian Journal of Cancer |
Bulletin du Cancer |
Journal of B.U.ON. |
International Journal of Women's Health |
Journal of Cancer Research and Therapeutics |
Journal of Cancer Science and Therapy |
Radiology and Oncology |
Cancer Therapy |
Medecine Palliative |
Gastrointestinal Cancer Research |
Asia-Pacific Journal of Clinical Oncology |
Open Cancer Journal |
Current Breast Cancer Reports |
Current Colorectal Cancer Reports |
Hematology/ Oncology and Stem Cell Therapy |
Esophagus |
Breast Care |
Molecular Medicine Reports |
Journal of Contemporary Brachytherapy |
International Journal of Cancer Research |
Community Oncology |
Iranian Journal of Cancer Prevention |
Journal of Breast Cancer |
Klinicka Onkologie |
Gineco.ro |
Oncology Reviews |
Chinese Journal of Oncology |
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi |
Translational Oncogenomics |
Cancer Forum |
Current Cancer Therapy Reviews |
Open Cancer Immunology Journal |
Case Reports in Oncology |
Chinese-German Journal of Clinical Oncology |
Psycho-Oncologie |
Onkologe |
Psicooncologia |
Tropical Medicine and Health |
European Journal of Oncology |
Oncology Letters |
Turk Onkoloji Dergisi |
Clinical Ovarian Cancer |
Current Urology |
Internet Journal of Oncology |
Wspolczesna Onkologia |
Oncologie |
Deutsche Zeitschrift fur Onkologie |
Indian Journal of Medical and Paediatric Oncology |
Japanese Journal of Lung Cancer |
Onkologia Polska |
Rare Tumors |
Current Gynecologic Oncology |
Open Clinical Cancer Journal |
Memo - Magazine of European Medical Oncology |
Academic Journal of Cancer Research |
Hot Topics in Oncology |
Cancer and Chemotherapy Reviews |
Lung Cancer: Targets and Therapy |
Best Practice Onkologie |
Chinese Journal of Cancer Prevention and Treatment |
Chinese Journal of Clinical Oncology |
Clinical and Experimental Medical Letters |
Meme Sagligi Dergisi / Journal of Breast Health |
Tumor Diagnostik und Therapie |
Voprosy Onkologii |
Advances in Breast Cancer Research |
Archive of Oncology |
Journal Africain du Cancer |
Onkologia i Radioterapia |
Turk Jinekolojik Onkoloji Dergisi |
European Journal of Oncology Pharmacy |
Gastric and Breast Cancer |
Journal of Leukemia and Lymphoma |
Journal of Practical Oncology |
Oncology Report |
Revisiones en Cancer |
Advances in Tumor Virology |
American Journal of Cancer Research |
Annals of Cancer Research and Therapy |
Anti-Cancer Agents in Medicinal Chemistry |
Asian Pacific Journal of Cancer Prevention |
Biomarkers in Cancer |
Blood Cancer Journal |
Brain Tumor Pathology |
Breast Cancer |
Canadian Oncology Nursing Journal |
Cancer Descovery |
Cancer Epidemiology |
Cancer Epidemiology, Biomarkers & Prevention |
Cancer Gene Therapy |
Cancer Genetics |
Cancer Genomics & Proteomics |
Cancer Imaging |
Cancer Immunity |
Cancer Journal (Sudbury, Mass.) |
Cancer Nursing Practice |
Cancer Treatment Communications |
Cancers |
Chinese Clinical Oncology |
Chinese Journal of Cancer Research |
Clinical Journal of Oncology Nursing |
Clinical Sarcoma Research |
Contemporary Oncology |
ecancermedicalscience |
Experimental Hematology & Oncology |
Experimental Oncology |
Forum of Clinical Oncology |
Frontiers in Oncology |
Genes, Chromosomes and Cancer |
Gynecologic Oncology |
Gynecologic Oncology Case Reports |
Indian Journal of Surgical Oncology |
Indonesian Journal of Cancer |
Journal of Cancer Policy |
Journal of Gastrointestinal Oncology |
Journal of Oncology Pharmacy Practice |
Journal of the Advanced Practitioner in Oncology |
Leukemia |
Leukemia Research Reports |
Lymphoma and Chronic Lymphocytic Leukemias |
Melanoma Research |
Nature Reviews Cancer |
Nutrition and Cancer |
Oncogene |
Oncogenesis |
Oncology Nursing Forum |
Open Surgical Oncology Journal |
Translational Cancer Research |
Translational Gastrointestinal Cancer |
Translational Lung Cancer Research |
Link between Immunotherapy and Serious Eye Condition: View of an Ophthalmologist
The surprising failure last month of a large clinical trial of a promising cancer immunotherapy drug from the biotech company Incyte has quickly reverberated across the pharmaceutical industry. Three companies have canceled, suspended, or downsized 12 other phase III trials of the compound, epacadostat, or two similar drugs, together slated to enroll more than 5000 patients with a variety of advanced cancers.
The companies say they aren't dropping the potential drugs, designed to unleash the immune system on cancer cells by blocking an enzyme called indoleamine (2,3)-dioxygenase (IDO). But the retrenching suggests that the frenzy to combine novel drugs with the wildly successful immunotherapies known as checkpoint inhibitors is outpacing the science. The IDO strategy, says neuroimmunologist Michael Platten of the University of Heidelberg in Germany, "has been moved to randomized clinical trials too fast, and now we realize [the enzyme is] still a black box."
A year ago, the future of IDO inhibitors looked bright. At the June 2017 meeting of the American Society of Clinical Oncology, doctors reported that epacadostat, given with the approved checkpoint inhibitor Opdivo, shrank tumors in 25 of 40 of melanoma patients—roughly double the historical response rate of Opdivo alone. A second epacadostat trial of 63 additional melanoma patients was also impressive, and the drug seemed to work well in other tumor types.
For complete news, please visit: Oncology News
May 25, 2018: Cancer research Breakthrough: Scientists reveal promising tumour-killing therapy
Cancer therapies which cut off blood supplies to dangerous tumours could be an effective new way of helping cancer patients, a study has found.
Cutting out the blood supply to tumours, in combination with existing chemotherapeutic drugs, could stop cancer tumours from growing. The ground-breaking research carried out on mice found tumour growth is better-reduced when the Beta3-integrin protein is targeted together with widely used cancer medication. The study, led by researchers at the University of East Anglia (UEA), was published today in the science journal EMBO Reports.
Lead researcher Dr Stephen Robinson, from UEA’s School of Biological Sciences, said: “Tumours must recruit their own blood supply to grow beyond a very small size and this process is called angiogenesis.
“Anti-angiogenic drugs stop tumours from growing their own blood vessels, and this in turn can slow the growth of the cancer, or shrink it.
“Targeting angiogenesis is therefore seen as crucial in many anti-cancer strategies.
“However many anti-angiogenetic therapies target proteins that help the functioning of a patient’s normal blood supply – and this can lead to nasty side effects including haemorrhage, strokes, high blood pressure, and fatigue.”
The researchers now hope to re-energise medical interest in microtubule-targeting agents (MTAs) – protein structures which help cells move and divide and are commonly used in chemotherapy. The scientists found the use of MTAs together with Beta3-integrin targeting is a more successful combo than Beta3-integrin targeting used alone.
Dr Robinson said: "This protein, Beta3-integrin, has been the focus of drug design over the last two decades because its expression is vastly increased in endothelial cells during blood vessel recruitment to tumours.
“We found that targeting the protein Beta3-integrin in combination with the use of microtubule-targeting agents (MTAs) could be a good way to stop tumours recruiting a blood supply to grow.
“This is really important because MTAs are already in clinic and commonly used as chemotherapies such as paclitaxel in cancer patients.
“Meanwhile Beta3-integrin inhibitors have been at the centre of cancer drug design for over 20 years and are well-tolerated in clinical trials.”
“We hope that this research could revitalise interest in this sort of therapy and lead to a re-purposing of MTAs as anti-angiogenic inhibitors, in combination with targeting Beta3 integrin.”
According to Cancer Research UK, more than 360,000 new cancer cases are diagnosed every year, based on 2013 to 2015 figures. In 2015 alone, around 183,000 men were diagnosed with concern and around 177,000 women were diagnosed. Breast, prostate, lung and bowel cancers are the most commonly diagnosed cancers. 2016 statistics reveal around 450 people die every day from cancer – more than quarter of all deaths in the country.
Source: http://bit.ly/2xmchsz
Preoperative Chemo Improves Outcomes in Node-Negative Gastric Cancer
In patients with gastric cancer who receive chemotherapy before gastrectomy, resulting in downstaged disease (cN+ ypN0), overall survival is similar to that of patients with natural node-negative disease (cN0 ypN0), according to a recent study. The report is the first to shine a light on this clinical question.
“In this retrospective cohort study, ypN status is a significant prognostic factor for overall survival [OS]. However, there is no survival difference between natural N0 and downstaged N0 patients,” said lead author Naruhiko Ikoma, MD, MS, a surgeon at the University of Texas MD Anderson Cancer Center, in Houston. He presented the study results at the 2018 Society for Surgical Oncology Annual Cancer Symposium (abstract 4).
In the United States, the standard of care for localized gastric cancer is preoperative chemotherapy followed by gastrectomy, based on data from multiple clinical trials showing that preoperative chemotherapy increases survival (N Engl J Med 2008[1];358:36-46; J Clin Oncol 2011;29[13]:1715-1721). Today, more than half of patients receive preoperative chemotherapy before gastrectomy (Cancer 2018;124[5]:998-1007).
This treatment shift brought about a need for changes to staging, and in 2018, the yp stage was introduced for gastric cancer patients who undergo preoperative chemotherapy or chemoradiation therapy in the American Joint Committee on Cancer’s AJCC Cancer Staging Manual, Eighth Edition. The staging manual uses the TNM system for gastric cancer staging, based on the size of the tumor (T), spread to nearby lymph nodes (N) and metastases to distant sites (M). In a previous analysis of patients at MD Anderson Cancer Center, those with node-negative disease on final pathology had uniformly good outcomes among patients with a status of ypT0-3, with no differences in survival (Gastric Cancer2018;21[1]:74-83). Because of limited data, the TNM group designation of ypT0 patients has not yet been defined. In addition, whether downstaged N0 patients (cN+ ypN0 disease) and natural N0 patients (cN0ypN0 disease) have similar survival is unknown.
Dr. Ikoma and his colleagues conducted a retrospective cohort study using a prospectively maintained database of patients with gastric cancer treated at MD Anderson Cancer Center. They included 316 patients with gastric adenocarcinoma, including Siewert type III gastroesophageal junction tumors, who underwent R0 resection for nonmetastatic disease after preoperative chemotherapy or chemoradiation therapy. The majority of the study population was male (62%) and white (56%); 23% had gastroesophageal junction tumors, and 76% received chemoradiation.
The researchers categorized patients into three groups based on nodal status: natural N0 (cN0/ypN0; n=94), downstaged N0 (cN+/ypN0; n=93), or node-positive (ypN+; n=129). Compared with the natural N0 disease group, the downstaged N0 disease group was more likely to have advanced clinical T category cases (P<0.001), to receive preoperative radiation therapy (90% vs. 76%), and to undergo total gastrectomy (61% vs. 39%). “The ypT category was grossly similar between those two groups,” Dr. Ikoma said.
With a median follow-up of 3.1 years, the median OS was 7.7 years, and the five-year OS was 60.3%. “There is no survival difference between natural N0 and downstaged N0 group, even though the downstaged N0 group had a more advanced baseline clinical T category,” Dr. Ikoma said. “As expected, node-positive patients had worse overall survival.” In a sensitivity analysis stratified by ypT category (ypT0-2 or ypT3-4; P=0.936 and P=608, respectively) and in a Cox regression analysis that adjusted for various factors that could influence survival, outcomes were similar in the natural N0 and downstaged N0 groups.
“ypN0 status is an important hallmark representing a successful preoperative treatment, regardless of pretreatment clinical nodal status in gastric cancer patients,” Dr. Ikoma said. The results can be generalized to other institutions, he said.
During a question-and-answer session after the presentation, Daniel Coit, MD, FACS, a surgeon at Memorial Sloan Kettering Cancer Center, in New York City, asked for further data. “Patients who get radiation therapy have an exaggerated local response that may impact both T and N downstaging, but may have a less impact on systemic disease, as opposed to those patients who are downstaged by chemotherapy alone,” he said. “Did you find any difference in outcome of those patients who achieved ypN0 status, depending on whether they got chemotherapy or chemoradiation?”
Dr. Ikoma responded that there was a distinction between those preoperative treatment groups. “Patients who had a complete response after chemoradiation had worse outcomes compared with if they received chemotherapy alone.”
This answer, Dr. Coit said, highlights the difference between assessing response at the primary and assessing the effect of a treatment on survival. “If you get a complete response after chemotherapy, that is likely to impact long-term survival. On the other hand, if you get a complete response after chemoradiation, where radiation exaggerates the complete response, you don’t see quite the same advantage. It is a subtle, but very important difference,” Dr. Coit said. “A lot of people advocate for chemoradiation therapy by saying there is a much higher local response rate and complete resection rate. That may be true, but it may be irrelevant to survival. People die of systemic disease, and that is what the treatment should be aimed at.” - Kate O’Rourke
Source: http://bit.ly/2xOVMFy [http://www.clinicaloncology.com]